NSE: AUROPHARMA

Aurobindo Pharma Ltd Share Price

Company information and financial fundamentals for Aurobindo Pharma Ltd, alongside its latest NSE share price.

Last price₹1,683.20+2.33% today · prev close ₹1,644.80
SectorHealthcare

About Aurobindo Pharma Ltd

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)

Classification: Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals · NSE symbol: AUROPHARMA

Company fundamentals

Market Cap₹ 96,218 Cr.
Current Price₹ 1,672
High / Low₹ 1,740 / 1,106
Stock P/E25.4
Book Value₹ 652
Dividend Yield0.24 %
ROCE12.9 %
ROE10.1 %
Face Value₹ 1.00

Figures are as reported by the company and compiled by screener.in (fetched 2026-11-03); they may lag the latest filing. Educational information, not investment advice.

Quarterly results (₹ crore)

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales7,5807,5677,7967,9798,3827,8688,2868,6468,8539,150
Expenses5,9205,9496,2306,4016,6226,2656,6086,8737,1037,271
Operating Profit1,6601,6181,5661,5781,7601,6031,6781,7731,7501,880
OPM %22%21%20%20%21%20%20%21%20%21%
Other Income14221136159135107122123117224
Interest8911111311811598959398102
Depreciation354404382419444406429465479487
Profit before tax1,2301,3241,2071,2001,3351,2071,2761,3391,2911,515
Tax %26%31%32%30%32%32%34%32%29%32%
Net Profit9079188178469038248489109211,032
EPS in Rs15.5115.6914.0714.5615.5614.2014.6115.6715.8617.95
Raw PDF——————————

Profit and loss, yearly (₹ crore)

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales16,46319,56423,09924,77523,45524,85529,00231,72433,65334,935
Expenses12,69115,61218,24919,49719,06021,14823,17625,16426,78327,854
Operating Profit3,7723,9524,8495,2784,3963,7075,8266,5606,8707,081
OPM %23%20%21%21%19%15%20%21%20%20%
Other Income105701663,195152291366613404586
Interest782633057449140290457384388
Depreciation5586689671,0551,1271,2451,5221,6491,7781,859
Profit before tax3,2413,0913,7437,3443,3732,6124,3805,0665,1125,420
Tax %25%24%24%27%22%26%28%31%31%—
Net Profit2,4232,3642,8445,3342,6471,9283,1693,4843,5033,711
EPS in Rs41.3640.3648.5691.0545.2032.9054.1560.0260.3464.09
Dividend Payout %6%6%6%4%20%23%8%0%7%—

Compounded growth

Compounded Sales Growth10 Years 9%5 Years 6%3 Years 11%TTM 9%
Compounded Profit Growth10 Years 6%5 Years 1%3 Years 23%TTM 11%
Stock Price CAGR10 Years 9%5 Years 20%3 Years 25%1 Year 45%
Return on Equity10 Years 14%5 Years 10%3 Years 11%Last Year 10%

Balance sheet (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital59595959595959595858
Reserves9,31311,62213,83216,76621,87124,51726,78129,78432,59537,833
Borrowings3,3644,7706,9675,8265,3392,8515,2866,6488,2638,073
Other Liabilities3,4644,4925,4146,1136,1476,2117,3798,2278,56612,232
Total Liabilities16,20020,94226,27128,76533,41633,63839,50544,71749,48258,196
Fixed Assets4,8346,5218,4759,3969,37410,53211,02414,49314,79417,407
CWIP1,4581,5831,6681,9863,0623,7475,3903,8694,9005,214
Investments2463123605555919975433722521,051
Other Assets9,66212,52715,76816,82720,39018,36222,54925,98329,53634,525
Total Assets16,20020,94226,27128,76533,41633,63839,50544,71749,48258,196

Cash flows (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3,2791,9551,6514,3813,3295,0162,3872,4353,9255,526
Cash from Investing Activity-1,787-1,927-2,904-1,563597-3,211-3,971-4,242-1,866-2,630
Cash from Financing Activity-1,9158641,919-1,947-1,365-2,9691,814800120-1,269
Net Cash Flow-4248926668712,561-1,164230-1,0072,1781,628
Free Cash Flow1,5947141142,9691,5032,693-323-1,0671,4082,468
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit118%70%61%106%87%143%84%72%86%107%

Efficiency ratios

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days68686468526266616677
Inventory Days246317304289333272275284295326
Days Payable1221281079710397125129117151
Cash Conversion Cycle191257260260282237216216244252
Working Capital Days51502535528455664944
ROCE %25%23%18%19%18%13%9%14%14%13%

Shareholding pattern (%)

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters51.80%51.82%51.82%51.82%51.82%51.82%51.82%51.82%51.88%51.88%
FIIs16.73%16.59%16.29%15.33%14.38%14.21%13.95%15.24%16.38%17.41%
DIIs24.77%25.14%25.21%26.23%26.93%27.60%27.66%25.82%25.05%24.37%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.05%0.05%0.05%
Public6.69%6.45%6.67%6.61%6.88%6.37%6.55%7.08%6.63%6.29%
No. of Shareholders2,38,6222,48,4882,57,9622,69,3232,72,2082,47,6622,36,8592,41,2982,39,0732,33,737

Exchange disclosures

Next results date

Aurobindo Pharma Ltd has a board meeting for financial results listed on 2026-11-04. Companies can reschedule; check the company's own announcement. Results calendar

Shown as filed with NSE. A filing shows that something happened, not why, and says nothing about what to do.

Compare AUROPHARMA with APOLLOHOSP →

Wondering what to do with Aurobindo Pharma Ltd?

This page shares company information and reported fundamentals. It does not tell you whether to buy, hold or sell. For a view that takes your own holding and goal into account, ask Samjho Bhai, our portfolio review tool.

Ask Samjho Bhai about AUROPHARMA →

How this page works · New to company fundamentals? Start learning.

Key terms: Nifty 50 · Price-to-earnings ratio · Earnings per share · Dividend yield · Market capitalisation

Other Healthcare stocks in the NSE

Apollo HospitalsNSE: APOLLOHOSPCiplaNSE: CIPLADr. Reddy's LaboratoriesNSE: DRREDDYMax HealthcareNSE: MAXHEALTHSun PharmaNSE: SUNPHARMA

Frequently asked questions

What is the NSE symbol for Aurobindo Pharma Ltd?

Aurobindo Pharma Ltd trades on the NSE under the symbol AUROPHARMA.

Where is Aurobindo Pharma Ltd listed?

Aurobindo Pharma Ltd is listed on the National Stock Exchange of India (NSE) under the symbol AUROPHARMA. It is not part of the NIFTY 50 or NIFTY 500 lists this site tracks.

Should I buy Aurobindo Pharma Ltd shares?

Market Dekho does not give buy, sell or hold recommendations and is not a SEBI-registered Research Analyst or Investment Adviser. To review a holding against your own goal and risk, you can use Samjho Bhai, or speak to a SEBI-registered adviser.

Prices are delayed and sourced from a public market-data provider; they may contain errors. This page is educational information, not investment advice.